These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29225140)

  • 1. Reactive astrocytes in Alzheimer's disease: A double-edged sword.
    Chun H; Lee CJ
    Neurosci Res; 2018 Jan; 126():44-52. PubMed ID: 29225140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy.
    Fakhoury M
    Curr Neuropharmacol; 2018; 16(5):508-518. PubMed ID: 28730967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.
    Smit T; Deshayes NAC; Borchelt DR; Kamphuis W; Middeldorp J; Hol EM
    Glia; 2021 Aug; 69(8):1852-1881. PubMed ID: 33634529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological phenotypes of astrocytes in Alzheimer's disease.
    Kim J; Yoo ID; Lim J; Moon JS
    Exp Mol Med; 2024 Feb; 56(1):95-99. PubMed ID: 38172603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic multiscale modelling of energy metabolism in human astrocytes reveals the impact of morphology changes in Alzheimer's Disease.
    Farina S; Voorsluijs V; Fixemer S; Bouvier DS; Claus S; Ellisman MH; Bordas SPA; Skupin A
    PLoS Comput Biol; 2023 Sep; 19(9):e1011464. PubMed ID: 37729344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease.
    Qin H; Zhou L; Haque FT; Martin-Jimenez C; Trang A; Benveniste EN; Wang Q
    J Neurochem; 2023 Nov; ():. PubMed ID: 37932959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy.
    Thomas SC; Alhasawi A; Appanna VP; Auger C; Appanna VD
    J Nutr Health Aging; 2015 Jan; 19(1):58-63. PubMed ID: 25560817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways.
    Preman P; Alfonso-Triguero M; Alberdi E; Verkhratsky A; Arranz AM
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of astrocytes in amyloid production and Alzheimer's disease.
    Frost GR; Li YM
    Open Biol; 2017 Dec; 7(12):. PubMed ID: 29237809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective.
    González-Reyes RE; Nava-Mesa MO; Vargas-Sánchez K; Ariza-Salamanca D; Mora-Muñoz L
    Front Mol Neurosci; 2017; 10():427. PubMed ID: 29311817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
    Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S
    Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of Astrocytes in Neuro-Vascular Unit and the Tripartite Synapse With Emphasis on Reactive Gliosis in the Context of Alzheimer's Disease.
    Liu CY; Yang Y; Ju WN; Wang X; Zhang HL
    Front Cell Neurosci; 2018; 12():193. PubMed ID: 30042661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive Astrocytes as Drug Target in Alzheimer's Disease.
    Assefa BT; Gebre AK; Altaye BM
    Biomed Res Int; 2018; 2018():4160247. PubMed ID: 29888263
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kelly P; Hudry E; Hou SS; Bacskai BJ
    Front Aging Neurosci; 2018; 10():219. PubMed ID: 30072889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.
    Yun SP; Kam TI; Panicker N; Kim S; Oh Y; Park JS; Kwon SH; Park YJ; Karuppagounder SS; Park H; Kim S; Oh N; Kim NA; Lee S; Brahmachari S; Mao X; Lee JH; Kumar M; An D; Kang SU; Lee Y; Lee KC; Na DH; Kim D; Lee SH; Roschke VV; Liddelow SA; Mari Z; Barres BA; Dawson VL; Lee S; Dawson TM; Ko HS
    Nat Med; 2018 Jul; 24(7):931-938. PubMed ID: 29892066
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Edison P; Donat CK; Sastre M
    Front Neurol; 2018; 9():625. PubMed ID: 30131755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in CNS neurodegenerative diseases.
    Stephenson J; Nutma E; van der Valk P; Amor S
    Immunology; 2018 Jun; 154(2):204-219. PubMed ID: 29513402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
    Polanco JC; Li C; Bodea LG; Martinez-Marmol R; Meunier FA; Götz J
    Nat Rev Neurol; 2018 Jan; 14(1):22-39. PubMed ID: 29242522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the brain's vascular and Alzheimer pathologies additive or interactive?
    Koncz R; Sachdev PS
    Curr Opin Psychiatry; 2018 Mar; 31(2):147-152. PubMed ID: 29232251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.
    Connolly NMC; Theurey P; Adam-Vizi V; Bazan NG; Bernardi P; Bolaños JP; Culmsee C; Dawson VL; Deshmukh M; Duchen MR; Düssmann H; Fiskum G; Galindo MF; Hardingham GE; Hardwick JM; Jekabsons MB; Jonas EA; Jordán J; Lipton SA; Manfredi G; Mattson MP; McLaughlin B; Methner A; Murphy AN; Murphy MP; Nicholls DG; Polster BM; Pozzan T; Rizzuto R; Satrústegui J; Slack RS; Swanson RA; Swerdlow RH; Will Y; Ying Z; Joselin A; Gioran A; Moreira Pinho C; Watters O; Salvucci M; Llorente-Folch I; Park DS; Bano D; Ankarcrona M; Pizzo P; Prehn JHM
    Cell Death Differ; 2018 Mar; 25(3):542-572. PubMed ID: 29229998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.